Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-04-779405
PubMed Identifier: 28588020
Publication URI: http://europepmc.org/abstract/MED/28588020
Type: Journal Article/Review
Volume: 130
Parent Publication: Blood
Issue: 6
ISSN: 0006-4971